Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
6
×
national top stories
new york blog main
6
×
san diego blog main
san francisco blog main
wisconsin blog main
wisconsin top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
biotech
fda
praluent
alzheimer's
donald trump
merck
pbm
regeneron pharmaceuticals
rejection
sanofi
vc
abeona therapeutics
affordable care act
agios pharmaceuticals
What
healthcare
6
×
bio
roundup
american
based
best
continue
crash
debate
industry
kind
moves
nash
new
people
pharmaceutical
policy
politicians
pressure
scalps
trump’s
u.s
america
becker
bigger
billions
biogen
cholesterol
continues
convoluted
deals
democrats
dollars
dreams
drug
drugs
eaton
exits
expensive
faces
Language
unset
Current search:
healthcare
×
" national blog main "
×
" new york blog main "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals